Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft Tissue Sarcoma After Pre-treatment Failure: an Open-label, Multicenter Phase II Study.
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2013
At a glance
- Drugs Panobinostat (Primary)
- Indications Soft tissue sarcoma
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms ESTIM; ESTIM-LBH
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2010 New trial record